Home » Topics » Regulatory » Patents

Patents
RSS

Protein farnesyltransferase inhibitors focus of research at Merck & Co.

Dec. 11, 1997

CRF antagonists from DuPont Merck for anxiety, depression and related disorders

Dec. 9, 1997

Alteon prepares new AGE inhibitors

Dec. 9, 1997

Byk Gulden presents new PDE IV inhibitors

Dec. 8, 1997

Egis prepares new AMPA receptor antagonists

Dec. 8, 1997

Analgesics under evaluation at Ortho

Dec. 8, 1997

Structurally distinct class of 5-HT1B antagonists prepared at SmithKline Beecham

Dec. 8, 1997

Alcon compounds with dual antioxidant/cysteine prodrug properties

Dec. 8, 1997

Endothelin-modulating compounds developed at Texas Biotechnology

Dec. 5, 1997

SKB reveals selective inhibitors of bacterial enzyme

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.